Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE)
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 22, 2021
- Source ID
- 10.1136/annrheumdis-2020-219803
Entities
People
- Daniel J. Wallace
- David M. Goldenberg
- Florence Figueras
- William A Wegener
Organizations
- United States Department of Defense